The short version of lipolysis fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-12-03. Anything still debated is marked as such rather than presented as settled.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Derived from C-terminal region of human growth hormone |
| Approximate molecular mass | About 1.8 kDa | Varies with sequence length and counterions |
| Confirmed receptor target | None established | No confirmed growth hormone receptor agonism |
| Reported in vitro activity | Lipolysis stimulation and lipogenesis inhibition | Observed mainly in adipocyte models; human relevance uncertain |
| Regulatory status | Not approved as a drug in major markets | May be treated differently across jurisdictions; not a recognized dietary ingredient in some countries |
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Most frequently seen, however, is the eastern or red-spotted newt (Notophthalmus viridescens), whose terrestrial eft form is often encountered on the open, dry forest floor. It has been estimated that salamanders represent the largest class of animal biomass in the Appalachian forests. Frogs and toads are of lesser diversity and abundance, but the wood frog (Rana sylvatica) is, like the eft, commonly encountered on the dry forest floor, while a number of species of small frogs, such as spring peepers (Pseudacris crucifer), enliven the forest with their calls. Salamanders and other amphibians contribute greatly to nutrient cycling through their consumption of small life forms on the forest floor and in aquatic habitats. Although reptiles are less abundant and diverse than amphibians, a number of snakes are conspicuous members of the fauna. One of the largest is the non-venomous black rat snake (Elaphe obsoleta obsoleta), while the common garter snake (Thamnophis sirtalis) is among the smallest but most abundant. The eastern copperhead (Agkistrodon contortrix) and the timber rattler (Crotalus horridus) are venomous pit vipers. There are few lizards, but the broad-headed skink (Eumeces laticeps), at up to 13 in (33 cm) in length, and an excellent climber and swimmer, is one of the largest and most spectacular in appearance and action. The most common turtle is the eastern box turtle (Terrapene carolina carolina), which is found in both upland and lowland forests in the central and southern Appalachians.
== Internet == Freedom House's Freedom on the Net2018 gave Thailand a score of 65 (0=best, 100=worst) for internet freedom. Not one of the eight ASEAN nations listed in the report achieved a "free" rating. Best was the Philippines; worst was Vietnam. Freedom House: In 2015 awarded Thailand an overall score of 63 ("not free") (0=best, 100=worst) for Internet freedom in the calendar year 2014, ranking 50 of 65 countries. In 2013 Thailand was rated as "partly free". International Telecommunication Union (ITU): In their 2012 report, ranked Thailand 92 of 155 countries for telecommunications infrastructure. Ookla Speedtest: The company known for its popular Internet utility, Speedtest, ranked all nations for rolling mean download speed in Mbps (megabit per second) in May 2015. Rankings are based on throughput over the previous 30 days to servers not more than 480 km from the client computer. Thailand ranked 52nd of 200 nations (20 Mbit/s). Other ASEAN nations ranked were Singapore (1 of 200 nations) 122 Mbit/s; Vietnam (61 of 200) 20 Mbit/s; Cambodia (110 of 200) 9 Mbit/s; Brunei (116 of 200) 8 Mbit/s; Malaysia (130 of 200) 7 Mbit/s; Laos (133 of 200) 7 Mbit/s; Indonesia (139 of 200) 7 Mbit/s; Myanmar (140 of 200) 7 Mbit/s; and the Philippines (176 of 200) 4 Mbit/s. According to Romanian internet security software firm Bitdefender, Thailand ranked fifth of 25 Asian nations in quantity of internet malware detected. India, Indonesia, China, and Vietnam were the top four cyber-security risks in Asia.
== Research == The broad range of research in medical genetics reflects the overall scope of this field, including basic research on genetic inheritance and the human genome, mechanisms of genetic and metabolic disorders, translational research on new treatment modalities, and the impact of genetic testing
== Sample preparation == Sample preparation is one of the most critical steps in NanoSIMS analysis, particularly when analysing biological samples. Specific protocols should be developed for individual experiments in order to best preserve not only the structure of the sample but also the true spatial distribution and abundance of molecules within the sample. As the NanoSIMS operates under ultra high vacuum, the sample must be vacuum compatible (i.e., volatile free), flat, which reduces varying ionization trajectories, and conductive, which can be accomplished by sputter coating with Au, Pt, or C. Biological samples, such as cells or tissue, can be prepared with chemical fixation or cryo-fixation and embedded in a resin before sectioning into thin slices (100 nm - 1μm), and placed on silicon wafers or slides for analysis. Sample preparation for metallographic samples is generally much simpler but a very good metallographic polish is required to achieve a flat, scratch free surface.
Sources: en.wikipedia.org
==== Invasion of Iraq ==== Planning for the Operation Iraqi Freedom began in December 2001; in 2002 several teams of 10th SFG and CIA SAD operatives were infiltrated into Iraqi Kurdistan in advance of hostilities. They were based in the Harir valley outside Irbil and tasked to develop ground truth intelligence while organising and training the Peshmerga; they were also there to monitor Ansar al-Islam and plan for a future operation against them. For the 2003 invasion of Iraq, CJSOTF-West (Combined Joint Special Operations Task Force-West/Task Force Dagger) was formed around the 5th SFG, their ODAs were tasked with two core missions: the first – to counter the SCUD TELs and by denying the Iraqi military the use of potential launch sites and the second – provide both intelligence-gathering and screening function in support of conventional forces to build up an accurate picture of Iraqi force dispositions in western Iraq. The Green Beret ODAs were deployed under the command and control of ODBs (Operational Detachment Bravo) which operated as roving AOBs (Advanced Operating Bases), these AOBs provided a mobile resupply function using their modified M1078 Light Medium Transport Vehicles which meant that the ODA patrols could operate for extended periods in enemy territory before linking up with a fighting patrol that would be escorting the AOBs for combat resupply.
The National Institutes of Health (NIH) is the primary agency of the United States federal government responsible for biomedical and public health research. It was founded in 1887 and is part of the United States Department of Health and Human Services (HHS). Many NIH facilities are located in Bethesda, Maryland, and other nearby suburbs of the Washington metropolitan area, with other primary facilities in Research Triangle Park in North Carolina and smaller satellite facilities located around the United States. The NIH conducts its scientific research through the NIH Intramural Research Program (IRP) and provides significant biomedical research funding to non-NIH research facilities through its Extramural Research Program. As of 2013, the IRP had 1,200 principal investigators and more than 4,000 postdoctoral fellows in basic, translational, and clinical research, being the largest biomedical research institution in the world, while, as of 2003, the extramural arm provided 28% of biomedical research funding spent annually in the U.S., or about US$26.4 billion. Basic research by the NIH contributed to every new drug approved by the Federal Drug Administration over the period 2010–2016. In early 2025, the Trump administration froze key NIH operations, and by January 2026 about 2,600 grants totaling $1.4 billion remained suspended, though some were reinstated due to court orders.
=== N05CX Hypnotics and sedatives in combination, excl. barbiturates === N05CX01 Meprobamate, combinations N05CX02 Methaqualone, combinations N05CX03 Methylpentynol, combinations N05CX04 Clomethiazole, combinations N05CX05 Emepronium, combinations N05CX06 Dipiperonylaminoethanol, combinations N05CX07 Diphenhydramine, combinations N05CX08 Carbromal, combinations N05CX09 Bromisoval, combinations N05CX11 Chloral hydrate, combinations N05CX13 Promethazine, combinations
Sources: en.wikipedia.org
However, many other acid-fast organisms—such as intestinal coccidia and parasitic helminths of the genus Schistosoma—lack mycolic acids yet display comparable acid-fastness, suggesting that other cell-wall structures, such as cyst walls or egg shells, may provide similar resistance to decolorization. Further histopathologic evidence supports this broader mechanism: in tissue sections, staining intensity is markedly reduced when bacterial cell walls are damaged or when xylene-based deparaffinization is used during specimen processing. A xylene-free, heat-based method has been shown to preserve cell-wall integrity and substantially improve detection of mycobacteria and other acid-fast organisms, particularly when using fluorescent Auramine O staining. Acid-fast organisms are difficult to characterize using standard microbiological techniques, though they can be stained using concentrated dyes, particularly when the staining process is combined with heat. Some, such as Mycobacteria, can be stained with the Gram stain, but they do not take the crystal violet well and thus appear light purple, which can still potentially result in an incorrect gram-negative identification. The most common staining technique used to identify acid-fast bacteria is the Ziehl–Neelsen stain, in which acid-fast species appear bright red against a blue background. Another method is the Kinyoun method, in which bacteria appear red against a green background.
=== N05CP Herbal hypnotics and sedatives === N05CP01 Valerian root N05CP02 Kava-kava rootstock N05CP03 St. John's wort N05CP04 Melissa herb N05CP05 Passionflower herb N05CP06 Valerian oil N05CP07 Hops N05CP30 Combinations N05CP50 Other herbal hypnotics and sedatives, combinations N05CP51 Valerian oil, combinations N05CP52 Kava-kava rootstock, combinations
1,2-Diarylethylamines are a class of psychoactive compounds defined by two aryl groups attached to adjacent carbon atoms on an ethylamine backbone. These compounds display a range of pharmacological activities, most notably as NMDA receptor antagonists, and have attracted attention as dissociative designer drugs that produce feelings of detachment from reality or oneself.
=== Endocrine === Hormone levels have been reported in gonadally intact people with CAIS in a number of studies. Hormone levels are similar to those of males, including high testosterone levels and relatively low estradiol levels. However, luteinizing hormone (LH) levels are elevated while sex hormone-binding globulin (SHBG) levels are more consistent with those of females. People with CAIS have low levels of progesterone similarly to males. The production rates of testosterone, estradiol, and estrone have been reported to be higher in gonadally intact with CAIS than in men.
Sources: en.wikipedia.org
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.
It is not approved as a prescription drug in the United States or the European Union for any indication. Regulatory status can differ by country, and it is often sold as a research chemical or in unapproved products. Such products are not equivalent to an approved medicine.
In the studies reported so far, AOD9604 does not appear to act through the growth hormone receptor and has not shown the typical IGF-1 increase caused by full-length hGH. Human data are limited, so this remains an area of uncertainty. It should not be assumed to have the same effects as hGH.
No. Major drug regulators have not approved AOD-9604 for weight loss or any other therapeutic indication. It remains an investigational compound studied in research settings.